SCHEMBL5216850

SCHEMBL5216850

COS(=O)(=O)CCc1ccc(Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.42
CNR2 P34972 1/20 0.41
KMT2A Q03164 5/20 0.41
MEN1 O00255 3/20 0.41
PTGES2 Q9H7Z7 4/20 0.41
ALDH1A1 P00352 3/20 0.41
AOC3 Q16853 1/20 0.40
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA4 P22748 1/20 0.38
CA9 Q16790 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
CTDSP1 Q9GZU7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7260130 0.81 ALDH1A1 (0.45) TAAR1ALDH1A1AOC3CA12CA1
SCHEMBL26719369 0.81 RECQL (0.58) TAAR1ALDH1A1CA12CA1CA2
SCHEMBL11516659 0.80 L3MBTL1 (0.46) KMT2AMEN1ALDH1A1KDM4E
SCHEMBL3250700 0.80 CA2 (0.48) KMT2AALDH1A1CA12CA1CA2
SCHEMBL198598 0.77 TAAR1 (0.50) TAAR1CNR2KMT2AMEN1PTGES2
SCHEMBL24541236 0.77 TSHR (0.53) CA12CA1CA2CA4CA9
SCHEMBL105528 0.75 TAAR1 (0.48) TAAR1CNR2KMT2AMEN1PTGES2
SCHEMBL27804764 0.75 TAAR1 (0.48) TAAR1CNR2KMT2AMEN1PTGES2
SCHEMBL8113789 0.74 RECQL (0.64) TAAR1KMT2AMEN1PTGES2AOC3
SCHEMBL29001383 0.74 MGLL (0.47) TAAR1CNR2KMT2AMEN1PTGES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313471-B1 BENZYLIDENE THIAZOLIDINEDIONES AND THEIR USE AS ANTIMYCOTIC AGENTS UCB SA (BE) 2007-04-11 EP disclosed
US-7105554-B2 Benzylidene thiazolidinediones and their use as antimycotic agents OXFORD GLYCOSCIENCES (UK) LTD. (GB) 2006-09-12 US disclosed
US-20040006112-A1 Benzylidene thiazolidinediones and their use as antimycotic agents OXFORD GLYCOSCIENCES (UK) LTD (GB) 2004-01-08 US disclosed
EP-1313471-A1 BENZYLIDENE THIAZOLIDINEDIONES AND THEIR USE AS ANTIMYCOTIC AGENTS Oxford GlycoSciences (UK) Limited (GB) 2003-05-28 EP disclosed
WO-2002017915-A1 BENZYLIDENE THIAZOLIDINEDIONES AND THEIR USE AS ANTIMYCOTIC AGENTS OXFORD GLYCOSCIENCES (UK) LIMITED (GB) 2002-03-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006112-A1 Benzylidene thiazolidinediones and their use as antimycotic agents SLC5A2, OXSR1, SLC5A1 TAAR1 525/4885CNR2 1121/4885KMT2A 2718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.